- MNMD +0.63%
Mind Medicine Inc (MNMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic Advances Amid ...
Yahoo Finance · 1 hour ago
Open | 9.35 |
High | 9.92 |
Low | 9.32 |
Mkt Cap | 690.69M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 9.55 |
52 Wk. Low | 2.41 |
52 Wk. High | 12.22 |
Related stocks
Psychedelic medicine biotech company
Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -23.86M | - |
Diluted EPS | -0.59 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$0.53 | - |
Q4 2023 | -$0.46 | -$0.59 |
Q3 2023 | -$0.67 | -$0.45 |
S&P FuturesES=F | 5,201.50-11.25 (-0.22%) |
Dow FuturesYM=F | 39,132.00-63.00 (-0.16%) |
Nasdaq FuturesNQ=F | 18,131.50-55.00 (-0.30%) |
106.07-1.60% | |
Airbnb, Inc.ABNB | 157.90-1.20% |
17.85-0.78% |